Opthea Limited

Opthea Limited (formerly Circadian Technologies) is a public Australian biotechnology company developing novel biologic therapies for the treatment of eye diseases.

Opthea's lead compound, OPT-302, blocks two members of the vascular endothelial growth factor family, namely VEGF-C and VEGF-D, which cause blood vessels to grow and leak.

Aberrant blood vessel growth and vascular leakage are hallmarks of several eye diseases including wet age-related macular degeneration (wet AMD).


Opthea is committed to improving vision in patients suffering with retinal eye diseases.

Contact Info:
Address: Level 1, 10 Wallace Avenue, Toorak, Melbourne, VIC 3142, AU

Website: www.opthea.com
Phone: 613 9826 0399

Opthea Limited-photo: https://pr.linkedin.com/company/opthea
Opthea Limited-photo: https://pr.linkedin.com/company/opthea
Opthea Limited- photo: https://seekingalpha.com/news/3747936-opthea-gets-enrollment-underway-in-late-stage-opt-302-wet-amd-program
Opthea Limited- photo: https://seekingalpha.com/news/3747936-opthea-gets-enrollment-underway-in-late-stage-opt-302-wet-amd-program

Top 7 Largest pharmaceutical companies in Oceania

  1. top 1 Mayne Pharma Group ltd
  2. top 2 Medical Developments International Ltd
  3. top 3 Opthea Limited
  4. top 4 Pharmaxis Limited
  5. top 5 Vita Life Sciences Limited
  6. top 6 IDT Australia Limited
  7. top 7 Recce Limited

Toplist Joint Stock Company
Address: 3rd floor, Viet Tower Building, No. 01 Thai Ha Street, Trung Liet Ward, Dong Da District, Hanoi City, Vietnam
Phone: +84369132468 - Tax code: 0108747679
Social network license number 370/GP-BTTTT issued by the Ministry of Information and Communications on September 9, 2019
Privacy Policy